Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2018-11-02FDA Approved: IRBESARTAN — Supplemental Application (Hisun Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for IRBESARTAN by Hisun Pharmaceuticals USA Inc. The approval indicates changes related to the a…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects [Phase 1]
A Phase 1 study evaluating the pharmacokinetics and safety of fimasartan and rosuvastatin co-administration in healthy male subjects.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: NSAID Use in Postpartum Hypertensive Women [Phase 4]
Phase 4 trial update on NSAID use in postpartum hypertensive women; study terminated with results posted in 2018.
-
FDA approval · 2018-10-30FDA Approved: HYDRALAZINE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Hydralazine Hydrochloride (HYDRALAZINE HYDROCHLORIDE) from Nivagen Pharmaceuticals, Inc. under a…
-
FDA approval · 2018-10-29FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Zydus Pharmaceuticals (USA) Inc.)
The FDA approved a supplemental application for metoprolol succinate submitted by Zydus Pharmaceuticals (USA) Inc., updating the labeling fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2018-10-26FDA Approved: METOPROLOL SUCCINATE — Original Application (BluePoint Laboratories)
FDA approved a generic metoprolol succinate product from BluePoint Laboratories under an original ANDA for the treatment of hypertension, an…
-
FDA approval · 2018-10-26FDA Approved: FELODIPINE — Original Application (Westminster Pharmaceuticals, LLC)
FDA approved Westminster Pharmaceuticals' felodipine extended-release tablets under an original generic application (ANDA). The product is a…
-
FDA approval · 2018-10-24FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
The FDA approved a supplemental application for IRBESARTAN (irbesartan) submitted by NorthStar RxLLC.
-
CLINICAL_TRIALS trial_result · 2018-10-22Clinical Trial Update: A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy
A post-marketing surveillance study evaluating the safety and efficacy of Twynsta (telmisartan + amlodipine) in Korean hypertensive patients…
-
CLINICAL_TRIALS trial_result · 2018-10-19Clinical Trial Update: Nebivolol Versus Metoprolol: Comparative Effects on Fatigue and Quality of Life [Phase 4]
A Phase 4 clinical trial comparing nebivolol to metoprolol evaluating fatigue and quality of life in hypertension.
-
CLINICAL_TRIALS trial_result · 2018-10-16Clinical Trial Update: Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan [Phase 4]
A Phase 4 trial assessing the efficacy and safety of fixed-dose combinations of amlodipine and candesartan for hypertension.
-
FDA approval · 2018-10-12FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) submitted by Organon LLC.
-
FDA approval · 2018-10-12FDA Approved: COZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Cozaar (losartan potassium) from Organon LLC.
-
FDA approval · 2018-10-12FDA Approved: CHLORTHALIDONE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved Dr. Reddy's Laboratories Inc.'s original application for chlorthalidone (generic diuretic) under ANDA210742.
-
FDA approval · 2018-10-12FDA Approved: CLONIDINE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approved Somerset Therapeutics' clonidine hydrochloride as a generic drug under an Original Application. The approval supports the gener…
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Effectiveness of a Mobile Technology Intervention for the Treatment of Depression [Phase 3]
Phase 3 clinical trial evaluating a mobile technology intervention for treating depression with data including depression and diabetes comor…
-
FDA approval · 2018-10-03FDA Approved: PRAZOSIN HYDROCHLORIDE — Original Application (ANI Pharmaceuticals, Inc.)
FDA approved ANI Pharmaceuticals' original application for prazosin hydrochloride (generic), enabling its marketing as a generic treatment f…
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: The Effect of Intranasal Vasoconstrictor Medications on Hemodynamic Parameters: A Randomized Double-blind, Placebo-controlled Trial. [NA]
A completed randomized double-blind, placebo-controlled trial evaluating intranasal vasoconstrictors and their effects on hemodynamic parame…
-
CLINICAL_TRIALS trial_result · 2018-10-02Clinical Trial Update: Renal Denervation in Hypertension [Phase 4]
Phase 4 clinical trial update on renal denervation for hypertension, including resistant hypertension.
-
CLINICAL_TRIALS trial_result · 2018-09-28Clinical Trial Update: EnligHTN German Observational Study of Renal Denervation for Uncontrolled Hypertension
This document reports the completion and posting of results for Abbott's EnligHTN German observational study evaluating renal denervation fo…
-
FDA approval · 2018-09-25FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for benazepril hydrochloride from Aurobindo Pharma Limited, enabling a generic version of the ACE in…
-
CLINICAL_TRIALS trial_result · 2018-09-21Clinical Trial Update: Prioritized Clinical Decision Support (CDS) to Reduce Cardiovascular Risk [NA]
Clinical trial update for Prioritized Clinical Decision Support (CDS) aimed at reducing cardiovascular risk; the study with hypertension and…
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension [Phase 4]
A Phase 4 study updating dose titration of lisinopril in children (1-18 years) with primary or secondary hypertension.
-
FDA approval · 2018-09-14FDA Approved: EPLERENONE — Original Application (Breckenridge Pharmaceutical, Inc.)
FDA approved Breckenridge Pharmaceutical's original ANDA for eplerenone (generic), a mineralocorticoid receptor antagonist used to treat hea…
-
CLINICAL_TRIALS trial_result · 2018-09-14Clinical Trial Update: IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN
Long-term follow-up study of patients with uncontrolled hypertension terminated; results posted in 2018.